| Dr Robin Yonna Feigelis, MD | |
|
74 Pascack Rd, Suite 10, Park Ridge, NJ 07656-1942 | |
| (201) 573-9266 | |
| (201) 573-8082 |
| Full Name | Dr Robin Yonna Feigelis |
|---|---|
| Gender | Female |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 41 Years |
| Location | 74 Pascack Rd, Park Ridge, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023087533 | NPI | - | NPPES |
| 049730401 | Medicaid | NJ |
| Facility Name | Location | Facility Type |
|---|---|---|
| Valley Home Care Inc. | Paramus, NJ | Home health agency |
| Valley Hospital | Ridgewood, NJ | Hospital |
| Englewood Hospital And Medical Center | Englewood, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medical Associates Of Englewood Pc | 1355512252 | 519 |
News Archive
Essentialis, Inc. announced today that the United States Patent & Trademark Office (USPTO) has issued U.S. Patent No. 7,799,777 entitled Salts of potassium ATP channel openers and uses thereof. The patent claims a novel composition of a polymorph of diazoxide choline, the active ingredient in the Essentialis lead product, DCCR. Essentialis has successfully completed phase 2b clinical trials with DCCR, showing a highly significant triglyceride reduction in dyslipidemic patients.
Kessler Foundation has been awarded a second two-year $150,000 grant from the Hearst Foundations to support a two-year post-doctoral fellowship in cognitive rehabilitation research.
HHS Secretary Kathleen Sebelius today announced $40 million in grants to 69 grantees in 41 states and the District of Columbia to help them find and enroll children who are uninsured but eligible for either Medicaid or the Children's Health Insurance Program (CHIP).
Medtronic, Inc. (NYSE: MDT) today announced that it has settled a patent lawsuit it initiated against W.L. Gore & Associates. Medtronic sued W.L. Gore in 2006 for patent infringement of selected patents in Medtronic's Jervis and Wiktor patent families.
Adding abemaciclib to hormonal therapy reduces the risk of cancer recurrence by 25% in patients with high-risk early hormone receptor positive (HR+) human epidermal growth factor receptor 2 negative (HER2-) breast cancer, according to results from a study at ESMO 2020.
› Verified 1 days ago
| Entity Name | Medical Associates Of Englewood Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952681918 PECOS PAC ID: 1355512252 Enrollment ID: O20110927000020 |
News Archive
Essentialis, Inc. announced today that the United States Patent & Trademark Office (USPTO) has issued U.S. Patent No. 7,799,777 entitled Salts of potassium ATP channel openers and uses thereof. The patent claims a novel composition of a polymorph of diazoxide choline, the active ingredient in the Essentialis lead product, DCCR. Essentialis has successfully completed phase 2b clinical trials with DCCR, showing a highly significant triglyceride reduction in dyslipidemic patients.
Kessler Foundation has been awarded a second two-year $150,000 grant from the Hearst Foundations to support a two-year post-doctoral fellowship in cognitive rehabilitation research.
HHS Secretary Kathleen Sebelius today announced $40 million in grants to 69 grantees in 41 states and the District of Columbia to help them find and enroll children who are uninsured but eligible for either Medicaid or the Children's Health Insurance Program (CHIP).
Medtronic, Inc. (NYSE: MDT) today announced that it has settled a patent lawsuit it initiated against W.L. Gore & Associates. Medtronic sued W.L. Gore in 2006 for patent infringement of selected patents in Medtronic's Jervis and Wiktor patent families.
Adding abemaciclib to hormonal therapy reduces the risk of cancer recurrence by 25% in patients with high-risk early hormone receptor positive (HR+) human epidermal growth factor receptor 2 negative (HER2-) breast cancer, according to results from a study at ESMO 2020.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robin Yonna Feigelis, MD 74 Pascack Rd, Suite 10, Park Ridge, NJ 07656-1942 Ph: (201) 573-9266 | Dr Robin Yonna Feigelis, MD 74 Pascack Rd, Suite 10, Park Ridge, NJ 07656-1942 Ph: (201) 573-9266 |
News Archive
Essentialis, Inc. announced today that the United States Patent & Trademark Office (USPTO) has issued U.S. Patent No. 7,799,777 entitled Salts of potassium ATP channel openers and uses thereof. The patent claims a novel composition of a polymorph of diazoxide choline, the active ingredient in the Essentialis lead product, DCCR. Essentialis has successfully completed phase 2b clinical trials with DCCR, showing a highly significant triglyceride reduction in dyslipidemic patients.
Kessler Foundation has been awarded a second two-year $150,000 grant from the Hearst Foundations to support a two-year post-doctoral fellowship in cognitive rehabilitation research.
HHS Secretary Kathleen Sebelius today announced $40 million in grants to 69 grantees in 41 states and the District of Columbia to help them find and enroll children who are uninsured but eligible for either Medicaid or the Children's Health Insurance Program (CHIP).
Medtronic, Inc. (NYSE: MDT) today announced that it has settled a patent lawsuit it initiated against W.L. Gore & Associates. Medtronic sued W.L. Gore in 2006 for patent infringement of selected patents in Medtronic's Jervis and Wiktor patent families.
Adding abemaciclib to hormonal therapy reduces the risk of cancer recurrence by 25% in patients with high-risk early hormone receptor positive (HR+) human epidermal growth factor receptor 2 negative (HER2-) breast cancer, according to results from a study at ESMO 2020.
› Verified 1 days ago
Paul C Mendelowitz, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 42 Whitney Hl, Park Ridge, NJ 07656 Phone: 201-822-5567 | |
Dr. Joseph Henry Hoffman, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 273 Vitmar Pl, Park Ridge, NJ 07656 Phone: 973-687-0355 |